(S)-Viloxazine Hydrochloride

CAS No. 56287-61-7

(S)-Viloxazine Hydrochloride( —— )

Catalog No. M33815 CAS No. 56287-61-7

(S)-Viloxazine Hydrochloride, the S-isomer of Viloxazine. Viloxazine is a selective norepinephrine reuptake inhibitor (NRI) that can be used as an antidepressant.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 46 In Stock
5MG 58 In Stock
10MG 78 In Stock
25MG 116 In Stock
50MG 167 In Stock
100MG 239 In Stock
500MG 591 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (S)-Viloxazine Hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    (S)-Viloxazine Hydrochloride, the S-isomer of Viloxazine. Viloxazine is a selective norepinephrine reuptake inhibitor (NRI) that can be used as an antidepressant.
  • Description
    (S)-Viloxazine Hydrochloride, the S-isomer of Viloxazine. Viloxazine is a selective norepinephrine reuptake inhibitor (NRI) that can be used as an antidepressant.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Neuroscience
  • Target
    Norepinephrine
  • Recptor
    Norepinephrine
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    56287-61-7
  • Formula Weight
    273.76
  • Molecular Formula
    C13H20ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.CCOc1ccccc1OC[C@@H]1CNCCO1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Milnacipran hydrochl...

    Milnacipran hydrochloride is a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the clinical treatment of fibromyalgia.

  • Reboxetine mesylate

    Reboxetine is a norepinephrine reuptake inhibitor with Ki of 8.2 nM.

  • Losulazine

    Losulazine is a peripheral sympathetic antihypertensive compound that can be taken orally. Losulazine causes relatively modest, transient depletion of dopamine and norepinephrine in brain regions protected by the blood-brain barrier.